Adam Bonislawski

Adam Bonislawski is a science writer with more than 10 years of experience covering genomic and proteomic research and diagnostics development with a focus on cancer and early detection. His writing ranges widely over academic research, companies, and technologies. The publications he writes for, GenomeWeb and 360Dx, are read by thousands of cancer researchers and doctors as well as a wide range of healthcare entrepreneurs and investors. In addition to his work as a science writer, Adam writes about business and real estate for The Wall Street Journal, New York Post, and Commercial Observer.